Literature DB >> 3753824

Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations.

T Hida, D Chandler, J E Arena, R Machemer.   

Abstract

We tested the vehicles of six different commercially available depot corticosteroids (Celestone Soluspan, Depo-Medrol, Decadron, Decadron L. A., Aristocort, and Kenalog) for possible toxicity when injected intravitreally. When tested on rabbit eyes, the Celestone Soluspan and the Depo-Medrol vehicles caused remarkable retinal degeneration with preretinal membrane formation or cataracts in their standard concentrations. Three other vehicles (Decadron and Decadron L. A.) caused localized retinal degeneration in twice the standard concentration. Thus, toxic effects can be caused by preservatives or inadequate osmolarity of the vehicles alone. The development of proliferative vitreoretinopathy in some cases of injections of intraocular depot corticosteroid can be explained by retinal necrosis and repair processes caused by these vehicles.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753824     DOI: 10.1016/0002-9394(86)90593-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  30 in total

Review 1.  Intraspinal steroids: history, efficacy, accidentality, and controversy with review of United States Food and Drug Administration reports.

Authors:  D A Nelson; W M Landau
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

2.  Intraocular pressure after intravitreal injection of triamcinolone acetonide.

Authors:  J B Jonas; I Kreissig; R Degenring
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

3.  Pseudo-endophthalmitis after intravitreal injection of triamcinolone.

Authors:  F K P Sutter; M C Gillies
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

Review 4.  [Ocular side effects and complications of intravitreal triamcinolone acetonide injection].

Authors:  G B Jaissle; P Szurman; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

5.  Evaluation of a single intravitreal injection of dexamethasone phosphate in vitrectomy surgery for diabetic retinopathy complications.

Authors:  G W Blankenship
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

6.  Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use.

Authors:  J García-Arumí; A Boixadera; J Giralt; V Martinez-Castillo; F Gomez-Ulla; B Corcostegui; E García-Arumí
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

7.  Influence of different purification techniques on triamcinolone yield and particle size spectrum.

Authors:  Peter Szurman; Radoslaw Kaczmarek; Gesine B Jaissle; Salvatore Grisanti; Matthias Lüke; Martin S Spitzer; Peter-Edgar Heide; Karl U Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-09-28       Impact factor: 3.117

8.  Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Authors:  J B Jonas; I Kreissig; P Hugger; G Sauder; S Panda-Jonas; R Degenring
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

9.  Effects of triamcinolone acetonide injections with and without preservative.

Authors:  Jost B Jonas
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

10.  Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).

Authors:  Baruch D Kuppermann; Leandro Cabral Zacharias; M Cristina Kenney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.